Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.
Ribonuclease P (RNase P) complexed with an external guide sequence (EGS) represents a novel nucleic acid-based gene interference approach to modulate gene expression. This enzyme is a ribonucleoprotein complex for tRNA processing. In Escherichia coli, RNase P contains a catalytic RNA subunit (M1 ribozyme) and a protein subunit (C5 cofactor). EGSs, which are RNAs derived from natural tRNAs, bind to a target mRNA and render the mRNA susceptible to hydrolysis by RNase P and M1 ribozyme. When covalently linked with a guide sequence, M1 can be engineered into a sequence-specific endonuclease, M1GS ribozyme, which cleaves any target RNAs that base pair with the guide sequence. Studies have demonstrated efficient cleavage of mRNAs by M1GS and RNase P complexed with EGSs in vitro. Moreover, highly active M1GS and EGSs were successfully engineered using in vitro selection procedures. EGSs and M1GS ribozymes are effective in blocking gene expression in both bacteria and human cells, and exhibit promising activity for antimicrobial, antiviral, and anticancer applications. In this review, we highlight some recent results using the RNase P-based technology, and offer new insights into the future of using EGS and M1GS RNA as tools for basic research and as gene-targeting agents for clinical applications.
Kim
Kihoon
K
Program in Comparative Biochemistry, University of California, Berkeley, CA 94720, USA.
Liu
Fenyong
F
D001483:Base Sequence; D005786:Gene Expression Regulation; D018390:Gene Targeting; D005821:Genetic Techniques; D006801:Humans; D008957:Models, Genetic; D034622:RNA Interference; D016337:RNA, Catalytic / Q000378:metabolism*; D043262:Ribonuclease P / Q000378:metabolism*
D016337:RNA, Catalytic; D043262:Ribonuclease P